(Q35567191)

8 August 2017

title

Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study (English)

1 reference

8 August 2017

1 reference

1 reference

6

Matthew B Stern

1 reference

8 August 2017

5

Ira R Katz

1 reference

8 August 2017

Daniel Weintraub

1

1 reference

8 August 2017

Donna Taraborelli

series ordinal

2

1 reference

8 August 2017

Knashawn H Morales

series ordinal

3

1 reference

8 August 2017

John E Duda

series ordinal

4

1 reference

8 August 2017

publication date

1 January 2006

1 reference

8 August 2017

number of pages

7

1 reference

Journal of Neuropsychiatry and Clinical Neurosciences

inferred from page(s)

published in

1 reference

8 August 2017

volume

18

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

377-383

1 reference

"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Depression in Parkinson's disease: conceptual issues and clinical challenges

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

A rating scale for depression

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

The assessment of anxiety states by rating

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

The neuropsychiatry of pathologic affect: an approach to evaluation and treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Diagnostic criteria for Parkinson disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Sertraline for the treatment of depression in Parkinson's disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

A self report measure of affective lability

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Altered serotonin metabolism in depressed patients with parkinson's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Parkinsonism: onset, progression, and mortality

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Psychiatric comorbidities in patients with Parkinson disease and psychosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

SSRIs in the treatment of depression in Parkinson's disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1761053

Parkinson's disease and anxiety: comorbidity with depression

26 September 2018

1 reference

12 December 2020

Dopamine and depression

1 reference

12 December 2020

Cognitive functions in major depression and Parkinson disease

1 reference

12 December 2020

A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients

1 reference

12 December 2020

Tolerability of paroxetine in Parkinson's disease: A prospective study

1 reference

12 December 2020

Paroxetine in Parkinson's disease: effects on motor and depressive symptoms

1 reference

12 December 2020

1 reference

12 December 2020

The inventory for depressive symptomatology (IDS): Preliminary findings

1 reference

12 December 2020

10.1176/JNP.2006.18.3.377

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference